- Patent Title: Delayed release deferiprone tablets and methods of using the same
-
Application No.: US16839928Application Date: 2020-04-03
-
Publication No.: US11357731B2Publication Date: 2022-06-14
- Inventor: Bernard Charles Sherman , Michael Spino
- Applicant: Chiesi Farmaceutici S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/20 ; A61K31/4412 ; A61K31/4422 ; A61P7/06 ; A61P25/28 ; A61P35/00
Abstract:
The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
Public/Granted literature
- US20200237674A1 DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME Public/Granted day:2020-07-30
Information query
